PFM Health Sciences as of June 30, 2024
Portfolio Holdings for PFM Health Sciences
PFM Health Sciences holds 77 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eli Lilly & Co. (LLY) | 13.4 | $270M | 299k | 905.38 | |
| Cytokinetics Com New (CYTK) | 4.7 | $95M | 1.8M | 54.18 | |
| Invesco Qqq Tr Unit Ser 1 Call Option (QQQ) | 4.4 | $90M | 187k | 479.11 | |
| Tenet Healthcare Corp Com New (THC) | 3.9 | $78M | 589k | 133.03 | |
| Merck & Co (MRK) | 3.7 | $74M | 596k | 123.80 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.5 | $70M | 149k | 468.72 | |
| Abbvie (ABBV) | 3.4 | $69M | 404k | 171.52 | |
| Edwards Lifesciences (EW) | 3.4 | $68M | 740k | 92.37 | |
| UnitedHealth Call Option (UNH) | 3.1 | $62M | 122k | 509.26 | |
| Intuitive Surgical Com New (ISRG) | 3.0 | $61M | 137k | 444.85 | |
| McKesson Corporation (MCK) | 2.8 | $57M | 98k | 584.04 | |
| Spdr Ser Tr S&p Biotech Call Option (XBI) | 2.7 | $55M | 595k | 92.71 | |
| Humana (HUM) | 2.3 | $47M | 125k | 373.65 | |
| Hca Holdings (HCA) | 2.0 | $40M | 125k | 321.28 | |
| Centene Corporation (CNC) | 2.0 | $40M | 599k | 66.30 | |
| Universal Hlth Svcs CL B (UHS) | 2.0 | $40M | 214k | 184.93 | |
| Stryker Corporation (SYK) | 1.9 | $39M | 114k | 340.25 | |
| Axsome Therapeutics (AXSM) | 1.9 | $38M | 467k | 80.50 | |
| Argenx Se Sponsored Adr (ARGX) | 1.8 | $37M | 87k | 430.04 | |
| Icon SHS (ICLR) | 1.8 | $37M | 117k | 313.47 | |
| Thermo Fisher Scientific (TMO) | 1.7 | $35M | 64k | 553.00 | |
| Penumbra (PEN) | 1.6 | $33M | 185k | 179.97 | |
| Danaher Corporation (DHR) | 1.6 | $31M | 126k | 249.85 | |
| Becton, Dickinson and (BDX) | 1.5 | $31M | 131k | 233.71 | |
| Anthem (ELV) | 1.5 | $30M | 55k | 541.86 | |
| Acadia Healthcare (ACHC) | 1.4 | $28M | 420k | 67.54 | |
| Boston Scientific Corporation (BSX) | 1.3 | $27M | 348k | 77.01 | |
| Dex (DXCM) | 1.3 | $26M | 231k | 113.38 | |
| Amgen (AMGN) | 1.3 | $25M | 81k | 312.45 | |
| Iqvia Holdings (IQV) | 1.2 | $24M | 112k | 211.44 | |
| Molina Healthcare (MOH) | 1.0 | $21M | 70k | 297.30 | |
| Ascendis Pharma A/s Note 2.250% 4/0 (Principal) | 1.0 | $20M | 18M | 1.12 | |
| Johnson & Johnson (JNJ) | 0.9 | $19M | 129k | 146.16 | |
| Praxis Precision Medicines I Com New (PRAX) | 0.9 | $19M | 453k | 41.36 | |
| Arcellx Common Stock (ACLX) | 0.9 | $17M | 312k | 55.19 | |
| Insmed Com Par $.01 (INSM) | 0.8 | $16M | 241k | 67.00 | |
| Essa Pharma Com New (EPIX) | 0.8 | $16M | 3.0M | 5.26 | |
| Biomarin Pharmaceutical Note 0.599% 8/0 (Principal) | 0.7 | $15M | 15M | 0.99 | |
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 0.7 | $14M | 71k | 202.89 | |
| Sarepta Therapeutics (SRPT) | 0.7 | $14M | 88k | 158.00 | |
| Celcuity (CELC) | 0.7 | $14M | 837k | 16.38 | |
| Oscar Health Cl A (OSCR) | 0.7 | $14M | 861k | 15.82 | |
| Immunovant (IMVT) | 0.6 | $13M | 473k | 26.40 | |
| Intra Cellular Therapies (ITCI) | 0.6 | $12M | 170k | 68.49 | |
| Erasca (ERAS) | 0.5 | $11M | 4.7M | 2.36 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.5 | $10M | 11M | 0.97 | |
| Sarepta Therapeutics Note 1.250% 9/1 (Principal) | 0.5 | $10M | 7.8M | 1.29 | |
| Madrigal Pharmaceuticals (MDGL) | 0.4 | $8.4M | 30k | 280.16 | |
| Syndax Pharmaceuticals (SNDX) | 0.4 | $8.0M | 387k | 20.53 | |
| Werewolf Therapeutics (HOWL) | 0.4 | $7.9M | 3.2M | 2.44 | |
| Caribou Biosciences (CRBU) | 0.3 | $6.7M | 4.1M | 1.64 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.3 | $6.6M | 1.1M | 6.04 | |
| Waters Corporation (WAT) | 0.3 | $6.0M | 21k | 290.12 | |
| Xenon Pharmaceuticals (XENE) | 0.3 | $5.9M | 151k | 38.99 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.3 | $5.7M | 636k | 9.03 | |
| Day One Biopharmaceuticals I (DAWN) | 0.3 | $5.5M | 397k | 13.78 | |
| Metagenomi (MGX) | 0.3 | $5.2M | 1.3M | 4.08 | |
| Cullinan Oncology (CGEM) | 0.3 | $5.2M | 296k | 17.44 | |
| Alkermes SHS (ALKS) | 0.2 | $4.9M | 205k | 24.10 | |
| Apellis Pharmaceuticals (APLS) | 0.2 | $3.2M | 83k | 38.36 | |
| Viking Therapeutics (VKTX) | 0.2 | $3.1M | 59k | 53.01 | |
| Outset Med | 0.1 | $2.9M | 745k | 3.85 | |
| Io Biotech (IOBT) | 0.1 | $2.7M | 2.3M | 1.17 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.1 | $2.5M | 293k | 8.70 | |
| Turnstone Biologics Corp (TSBX) | 0.1 | $2.4M | 932k | 2.62 | |
| Generation Bio | 0.1 | $2.2M | 788k | 2.82 | |
| Sagimet Biosciences Com Ser A (SGMT) | 0.1 | $2.2M | 649k | 3.42 | |
| Pmv Pharmaceuticals (PMVP) | 0.1 | $2.1M | 1.3M | 1.62 | |
| Celldex Therapeutics Com New (CLDX) | 0.1 | $1.9M | 52k | 37.01 | |
| Inhibrx Biosciences (INBX) | 0.1 | $1.9M | 136k | 14.17 | |
| Keros Therapeutics (KROS) | 0.1 | $1.5M | 33k | 45.70 | |
| Uniqure Nv SHS (QURE) | 0.1 | $1.2M | 275k | 4.48 | |
| Iovance Biotherapeutics (IOVA) | 0.1 | $1.2M | 153k | 8.02 | |
| Waystar Holding Corp (WAY) | 0.0 | $753k | 35k | 21.50 | |
| Tenaya Therapeutics (TNYA) | 0.0 | $689k | 222k | 3.10 | |
| Sana Biotechnology (SANA) | 0.0 | $605k | 111k | 5.46 | |
| Boundless Bio (BOLD) | 0.0 | $544k | 141k | 3.87 |
